Category: Latest News
-
Gold Pulls Back After Two-Week High Amid Fed Controversy
Gold prices retreated in Asian trading on Wednesday following a rally to a two-week peak, triggered by concerns over U.S. President Donald Trump’s attempt to remove Federal Reserve Governor Lisa Cook, raising questions about the central bank’s independence. The yellow metal initially jumped after Trump’s late-Monday announcement to immediately dismiss Cook over alleged mortgage fraud,…
-
Oil Markets Steady as Secondary Tariffs on India Take Center Stage
Oil prices held near recent lows in Asian trading on Wednesday, after sharp declines in the previous session, as traders weighed the impact of new U.S. tariffs on India and smaller-than-anticipated declines in U.S. crude inventories. By 22:00 ET (02:00 GMT), Brent crude for October delivery edged down 0.1% to $67.16 per barrel, while October…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, Markets Watch: Nvidia Earnings, India Tariffs, and French Political Turmoil
U.S. stock futures edged up Wednesday as investors anticipated key earnings from AI heavyweight Nvidia, which could shape market sentiment in the near term. At the same time, hefty U.S. tariffs on Indian imports have now taken effect, while France faces renewed political uncertainty. Nvidia’s results take center stage Nvidia (NASDAQ:NVDA), a bellwether for the…
-
U.S. Stocks Finish Choppy Trading Day Mostly Higher
Stocks showed a lack of direction throughout much of the trading session on Tuesday but managed to end the day mostly higher. The major averages all moved back to the upside after ending the previous session in negative territory. The major averages finished the day just off their highs of the session. The Nasdaq advanced…
-
Allarity Therapeutics Wins FDA Fast Track Designation for Ovarian Cancer Drug Candidate Stenoparib
Allarity Therapeutics, Inc. (NASDAQ:ALLR) announced Tuesday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to stenoparib, its investigational treatment for advanced ovarian cancer. The company’s shares rocketed on the news, gaining around 95% in pre-market trading. Fast Track status is intended to speed up the development and review of drugs…
-
Spotify to Launch In-App Messaging to Boost User Engagement
Spotify Technology (NYSE:SPOT) is set to roll out a new messaging feature for both its free and premium users as part of efforts to attract a larger audience and strengthen its position against competitors. The Swedish streaming service announced Tuesday that the update will allow users to chat and share music with others they’ve previously…
-
Trump Media and Crypto.com Announce Strategic Alliance
Trump Media & Technology Group Corp (NASDAQ:DJT) revealed on Tuesday that it has entered into a strategic partnership with the cryptocurrency platform Crypto.com. Under the terms of the deal, Trump Media will acquire around $105 million worth of CRO, Crypto.com’s native token. In exchange, Crypto.com will invest $50 million in Trump Media shares. The collaboration…
-
UBS highlights AI’s growth potential despite short-term risks
UBS advised investors to look past near-term challenges in tech stocks, emphasizing that artificial intelligence (AI) remains a key driver of long-term portfolio growth. In a note, the bank pointed out that U.S. equities pulled back on Monday after a recent rally fueled by Federal Reserve Chair Jerome Powell’s indication that rate cuts may be…
-
Gaotu Techedu shares climb as Q2 revenue surpasses expectations
Gaotu Techedu Inc. (NYSE:GOTU) saw its shares rise 4.8% on Thursday after reporting second-quarter revenue that exceeded analyst projections, despite a slight miss on earnings. The Chinese edtech company posted revenue of RMB1.39 billion ($215.5 million) for the quarter ending June 30, 2025, above the RMB1.24 billion expected by analysts and reflecting a 37.6% increase…
-
EHang shares drop 10% as revenue falls short despite strong growth
EHang Holdings Limited (NASDAQ:EH) saw its shares decline 10.34% in pre-market trading Tuesday after reporting second-quarter revenue that fell slightly below analyst expectations, despite strong year-over-year and sequential growth. The urban air mobility firm posted revenue of RMB147.2 million ($20.5 million) for Q2, missing the RMB150.93 million consensus estimate. Nonetheless, this represented a 44.2% increase…